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rlangen, Germany
omputed tomography (CT) imaging of the coronary
rteries is challenging. The coronary vessels are small, and
hey move very rapidly, so that tremendously high spatial
nd temporal resolution are necessary to obtain sharp
mages of the coronary tree. The first CT system success-
ully used to visualize the coronary arteries was the electron
eam tomography (EBT) scanner, which became available
n the late 1980s and early 1990s and was also called
ultrafast CT” because of its ability to acquire images at
nprecedented speed. With an exposure time of 100 ms/
mage, the EBT scanner allowed faster imaging than most
ultidetector CT systems in use today, but limitations
ncluded a spatial resolution much lower than that of current
T scanners, rather high image noise, and a long overall
mage acquisition time (patients typically had to hold their
reath for more than 30 s).
See page 1335
The main application of EBT was the detection and
uantification of coronary artery calcification. In addition,
BT first demonstrated the ability of CT imaging to obtain
noninvasive coronary angiograms” after injection of a
ontrast agent. In the mid 1990s, this new development
eceived tremendous interest and fueled the surprisingly
apid evolution of CT technology, much of which was
riven by the desire to improve the ability of CT to visualize
he coronary arteries. Today, 64-slice CT systems, which
llow rather stable imaging of the coronary vessels, are
idely available. Coronary computed tomography angiog-
aphy (CTA) is considered an “appropriate” clinical tool in
elected situations, including ruling out coronary stenoses in
ymptomatic patients with intermediate likelihood of coro-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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ildung und Forschung, Germany.ary artery disease (1). Although numerous comparisons of
T imaging to invasive angiography have been published
nd demonstrate a high accuracy for the detection of
obstructive” coronary artery lesions, very little is known
bout the prognostic implications of coronary CTA.
The study presented by Ostrom et al. (2) in this issue of
he Journal provides data concerning the prognostic value of
ontrast-enhanced CT visualization of the coronary arteries.
he investigators followed up 2,538 patients studied by
ontrast-enhanced EBT for up to 15 years. Based on their
arge number of patients, complete follow-up, and long
bservation period, they are able to demonstrate that the
resence of obstructive and nonobstructive coronary artery
esions seen in contrast-enhanced EBT is predictive of
ortality above and beyond traditional risk factors. Dem-
nstration of lesions is also a better predictor than the mere
ssessment of coronary calcification. The severity of coro-
ary lesions and the extent of disease (e.g., 1 affected vessel
s. several affected vessels) were associated with mortality
ates. After adjustment for risk factors and coronary calcium
core, patients with obstructive lesions seen in EBT angiog-
aphy had an approximately 2-fold risk of death as com-
ared to patients without detectable atherosclerosis. Inter-
stingly, noncalcified, nonstenotic plaque was found to be
redictive only if its extent was substantial: only patients
ho had all 3 vessels affected had an increased mortality.
Obviously, the study by Ostrom et al. (2) has some
imitations—for example, it is unclear how many patients
ere symptomatic and what treatment was initiated based
n the EBT results—but it does provide very interesting
arly data concerning the prognostic implications of coro-
ary plaque detected in contrast-enhanced CT imaging. As
s typically the case with new and exciting research results,
he study answers some questions, but also raises many new
nes, some of which are outlined below.
ymptomatic patients or asymptomatic individuals? In
y opinion, it is important to carefully distinguish 2 clinical
cenarios. The first scenario is the use of coronary CTA for
ymptomatic patients. For some subgroups of patients who
o not have a high likelihood of coronary artery stenoses,
his is currently considered appropriate (1). Clinically, the
im of CT will be ruling out coronary artery stenoses to
void invasive catheterization. Prognostic studies are needed
o clarify whether it is safe to replace invasive angiography
y CT, and also to determine whether patients in whom CT
ules out the presence of obstructive lesions (thus avoiding
nvasive angiography) but demonstrates the presence of
onobstructive plaque are at higher risk of cardiac events
han are patients with entirely normal coronary arteries on
T. This determination is important in order to make
ppropriate recommendations regarding risk modification
n such patients. The study by Ostrom et al. (2) provides
ome data in this respect.
The second scenario is that of the asymptomatic patientor whom coronary CTA is performed for the sole purpose
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October 14, 2008:1344–6 Prognostic Value of Coronary CTAf “risk stratification” in a primary prevention context. This
s quite a different setting. Most patients in the study by
strom et al. (2) probably had symptoms, and similarly, the
ew other available studies that have investigated prognostic
mplications of coronary CTA were all conducted in pa-
ients who were largely symptomatic (3–7). It is important
ot to use results obtained from such patient groups to
ustify coronary CT “screening” of asymptomatic patients.
retest likelihoods and future event risks are substantially
ower, and the balance between test benefit and associated
isks (and costs) may be profoundly different from that of
ymptomatic patients. The use of contrast-enhanced coro-
ary CTA for risk stratification for asymptomatic patients is
urrently considered an “inappropriate” application (1), and
n my opinion, the study by Ostrom et al. (2) will not
hange that.
id technology matter? The study by Ostrom et al. (2)
as conducted using EBT, which is not widely available
nymore. The EBT data collected by Ostrom et al. (2) are
xtremely valuable because they allow a long follow-up
eriod, but EBT has meanwhile been replaced by multide-
ector computed tomography (MDCT), which has higher
patial resolution and, in general, better image quality than
BT. However, this does not mean that detection of plaque
y MDCT is easy. Data sets of impeccable quality are
equired to assess the presence or absence of nonobstructive
laque, and even in expert hands, neither sensitivity nor
pecificity is perfect (8). With adequate image quality,
owever, it should be expected that more noncalcified
laque will be identified in MDCT as compared to EBT—a
ouble-edged sword. On the one hand, it will make it less
ikely that a patient with a future event will be missed by
DCT. On the other hand, I suspect that even more plaque
ay be detected by MDCT, and that may lead to a larger
umber of patients being placed in a “high risk” category.
gain, it is important to keep in mind that only plaque in all
vessels was predictive of future events in the study by Ostrom
t al. (2). Small, localized plaques have so far not been tied to
n increased event risk.
ould the mere detection of plaque be enough? Ostrom
t al. (2) used a “yes/no” model to assess the presence of
bstructive and nonobstructive coronary lesions by CT.
ost likely, that will not be sufficient in the future (Fig. 1).
ot all “nonobstructive lesions” are alike—for example, they
ay be small, confined to the vessel wall, and predominantly
alcified, or they can be large, positively remodelled, and
argely noncalcified. However, as noncalcified plaque is
bserved very frequently by contrast-enhanced coronary
TA (more than one-half of all patients in the study by
strom et al. [2], and about 30% of patients in a different
tudy [9]), merely evaluating the presence of plaque may
lace too many individuals in a “high-risk” category, with
he consequence of (expensive) risk modification treatment
s well as considerable emotional stress. Efforts will have to
e undertaken to identify characteristics that are associated
ith increased risk of future events, whether this may be
lobal features (such as plaque volume), specific aspects of aFigure 1 Visualization of Proximal and Mid
LAD by Contrast-Enhanced MDCT in 3 Patients
Visualization of the proximal artery and mid left anterior descending coronary
artery (LAD) by contrast-enhanced multidetector computed tomography (MDCT) in 3
different patients. (A) Visualization of a small calcified plaque (large arrow) along
with some noncalcified plaque (small arrow) in the mid left anterior descending
coronary artery. (B) While nominally this patient also demonstrates calcified (large
arrow) and noncalcified, nonobstructive plaque (small arrow), the lesion has differ-
ent characteristics as compared with A. The noncalcified plaque component is
substantially larger, and the lesion displays pronounced positive remodeling.
Potentially, this lesion may be more “vulnerable” than the lesion in A. (C) Not in
all cases is image quality high enough to reliably rule in or rule out small noncalci-
fied plaque. Although coronary stenoses can be ruled out, image noise prevents
assessing the presence of noncalcified plaque in this low-dose image.
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Prognostic Value of Coronary CTA October 14, 2008:1344–6iven plaque (such as remodeling), or a combination of both
10). A small, noncalcified plaque may actually be pretty
armless and in fact, the absence of substantial amounts of
oncalcified plaque may at some point allow “downstaging” of
atients concerning their risk, but future research will need to
ddress this issue.
ow much can we afford to spend? Even when leaving
he economic implications of CT angiography for risk
tratification completely aside, this test comes at a cost: the
njection of contrast and the associated radiation exposure
lace CTA in a completely different category as compared
o, for example, coronary calcium imaging. Low radiation
ose protocols are becoming increasingly available for CTA,
ut flawless image quality is necessary to be able to assess the
resence or absence of plaque with a reasonable degree of
ertainty. Studies performed at very low dose or affected by
ther sorts of artifacts may be sufficient to rule out the
resence of coronary stenosis, but not necessarily to visualize
r even characterize plaque (Fig. 1). Contrast and radiation
isks have to be assessed very carefully if ever considering the
se of CTA in primary prevention settings.
In summary, the paper by Ostrom et al. (2) is helpful and
ery welcome as it provides more data on the prognostic
mplications of coronary visualization using CT techniques.
t contains the very reassuring message that the absence of
tenosis and nonobstructive plaque is associated with a good
rognosis, even in a patient population that was most likely
argely symptomatic. However, the results do not justify the
se of CTA as a screening tool for asymptomatic, primary
revention patients.
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